John C.K. Milligan, IV
2017
In 2017, John C.K. Milligan, IV earned a total compensation of $1.8M as President and Secretary at TherapeuticsMD, a 135% increase compared to previous year.
Compensation breakdown
Bonus | $40,000 |
---|---|
Non-Equity Incentive Plan | $299,250 |
Option Awards | $1,026,333 |
Salary | $450,000 |
Other | $24,446 |
Total | $1,840,029 |
Milligan received $1M in option awards, accounting for 56% of the total pay in 2017.
Milligan also received $40K in bonus, $299.3K in non-equity incentive plan, $450K in salary and $24.4K in other compensation.
Rankings
In 2017, John C.K. Milligan, IV's compensation ranked 5,909th out of 14,666 executives tracked by ExecPay. In other words, Milligan earned more than 59.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,909 out of 14,666 | 60th |
Division Manufacturing | 2,156 out of 5,772 | 63rd |
Major group Chemicals And Allied Products | 672 out of 2,075 | 68th |
Industry group Drugs | 520 out of 1,731 | 70th |
Industry Pharmaceutical Preparations | 412 out of 1,333 | 69th |
Source: SEC filing on April 27, 2018.
Milligan's colleagues
We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2017.